Hans‐Georg Kräusslich
0000-0002-8756-329X
Publication & Citation Trends
Publications
0 total
Live‐virus neutralization of the omicron variant in children and adults 14 months after SARS‐CoV‐2 wild‐type infection OA
Cited by 3
Semantic Scholar
The phenuivirus Toscana virus makes an atypical use of vacuolar acidity to enter host cells OA
Cited by 8
Semantic Scholar
Scalable RT‐LAMP‐based SARS‐CoV‐2 testing for infection surveillance with applications in pandemic preparedness OA
Cited by 10
Semantic Scholar
Generation of Human Lung Organoid Cultures from Healthy and Tumor Tissue to Study Infectious Diseases OA
Cited by 27
Semantic Scholar
1142. Plasma with high titers of anti-SARS-Cov2 antibodies improves outcome of COVID-19 in patients with hematological malignancy and cancer in a randomized controlled trial
Cited by 0
Semantic Scholar
Anti-SARS-CoV-2 antibody-containing plasma improves outcome in patients with hematologic or solid cancer and severe COVID-19: a randomized clinical trial OA
Cited by 68
Semantic Scholar
Nuclear Capsid Uncoating and Reverse Transcription of HIV-1. OA
Cited by 72
Semantic Scholar
Seroconversion Rates After the Second COVID-19 Vaccination in Patients With Systemic Light Chain (AL) amyloidosis OA
Cited by 1
Semantic Scholar
Research Topics
HIV Research and Treatment
(205)
HIV/AIDS drug development and treatment
(97)
Bacteriophages and microbial interactions
(38)
Cytomegalovirus and herpesvirus research
(33)
SARS-CoV-2 and COVID-19 Research
(31)
Affiliations
National Institutes of Health
European Molecular Biology Organization
State University of New York
Leibniz Institute of Virology (LIV)
Max Planck Society